[
    [
        {
            "time": "2018-09-02",
            "original_text": "乐普医疗第一期员工持股计划买入2070万股 高管今年以来多次增持",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "员工持股计划",
                    "高管增持"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗第一期员工持股计划买入2070万股 高管今年以来多次增持",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-02",
            "original_text": "【华泰医药代雯团队】医药板块2018中报总结：增长稳健，强者恒强",
            "features": {
                "keywords": [
                    "医药板块",
                    "中报总结",
                    "增长稳健"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【华泰医药代雯团队】医药板块2018中报总结：增长稳健，强者恒强",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-02",
            "original_text": "处方药压力渐显，非药景气依旧｜【光大医药·2018H1总结】",
            "features": {
                "keywords": [
                    "处方药",
                    "压力",
                    "非药景气"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "处方药压力渐显，非药景气依旧｜【光大医药·2018H1总结】",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-02",
            "original_text": "招商证券：医药行业维持较高景气 关注优质白马及高成长个股",
            "features": {
                "keywords": [
                    "招商证券",
                    "医药行业",
                    "景气",
                    "优质白马",
                    "高成长个股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "招商证券：医药行业维持较高景气 关注优质白马及高成长个股",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-02",
            "original_text": "【太平洋证券策略】社保基金2018年2季度持仓分析",
            "features": {
                "keywords": [
                    "社保基金",
                    "持仓分析",
                    "2018年2季度"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【太平洋证券策略】社保基金2018年2季度持仓分析",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-09-02",
            "original_text": "医疗保健：203个药品辽宁议价未成功",
            "features": {
                "keywords": [
                    "医疗保健",
                    "药品",
                    "辽宁议价未成功"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗保健"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医疗保健：203个药品辽宁议价未成功",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-09-02",
            "original_text": "机构动向：外资减消费加周期 私募在“吃面”",
            "features": {
                "keywords": [
                    "机构动向",
                    "外资",
                    "消费",
                    "周期",
                    "私募"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "机构动向：外资减消费加周期 私募在“吃面”",
                "Correlation": 4,
                "Sentiment": 3,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-09-02",
            "original_text": "【山证医药】医药生物行业周报（20180827-20180902）：行业整体业绩表现优异，关注细分领域",
            "features": {
                "keywords": [
                    "医药生物",
                    "周报",
                    "业绩表现优异",
                    "细分领域"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【山证医药】医药生物行业周报（20180827-20180902）：行业整体业绩表现优异，关注细分领域",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 5
            }
        }
    ]
]